Interdependence of Baseline Correction Method and Covariance Structure for Crossover TQT Studies

REFERENCES

• Anand , S. P. , Murray , S. C. , Koch , G. G. ( 2010 ). Sample size calculations for crossover through QT studies: Satisfaction of regulatory threshold and assay sensitivity . Journal of Biopharmaceutical Statistics 20 : 563 – 579 .
   PubMed Web of Science ®Google Scholar
• Bloomfield , D. M. , Kost , J. T. , Ghosh , K. , Hreniuk , D. , Hickey , L. A. , Guitierrez , M. J. , Gottesdiener , K. , Wagner , J. A. ( 2008 ). The effect of moxifloxacin on QTc and implications for the design of through QT studies . Clinical Pharmacology and Therapeutics 84 ( 4 ): 475 – 480 .
   PubMed Web of Science ®Google Scholar
• Fridericia , L. S. ( 2003 ). The duration of systole in an electrocardiogram in normal humans and in patients with heart disease. 1920 . Annals of Noninvasive Electrocardiology 8 ( 4 ): 343 – 351 .
   PubMed Web of Science ®Google Scholar
• Guerin , L. , Stroup , W. ( 2000 ). A simulation study to evaluate PROC MIXED analysis of repeated measures data. In: Proceedings of the Twelfth Annual Conference on Applied Statistics in Agriculture. Manhattan: Kansas State University .
   Google Scholar
• Gomez , E. V. , Schaalje , G. B. , Fellingham , G. W. ( 2005 ). Performance of the Kenward–Roger method when the covariance structure is selected using AIC and BIC . Communications in Statistics—Simulation and Computation 34 : 377 – 392 .
   Web of Science ®Google Scholar
• ICH E14 guidance. (2005). E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs. http://www.fda.gov/ RegulatoryInformation/Guidances/ucm129335.htm
   Google Scholar
• Jones , B. , Kenward , M. G. (2003). Design and Analysis of Cross-Over Trials. , 2nd ed. London , UK : Chapman and Hall.
   Google Scholar
• Kenward , M. G. , Roger , J. H. ( 2009 ). The use of baseline covariates in crossover studies . Biostatistics 11 : 1 – 17 .
   PubMed Web of Science ®Google Scholar
• Li , X. , Maes , A. , Panebiance , D. ( 2010 ). QTc model misspecification may cause spurious carryover effects. Joint Statistical Meetings. Vancouver, Canada, July 31 .
   Google Scholar
• Littell , R. C. , Pendergast , J. , Natarajan , R. ( 2000 ). Modelling covariance structure in the analysis of repeated measures data . Statistics in Medicine 19 : 1793 – 1819 .
   PubMed Web of Science ®Google Scholar
• Malik , M. , Hnatkova , K. , Batchvarov , V. , Gang , Y. , Smetana , P. , Camm , A. J. ( 2004 ). Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation . Pacing in Clinical Electrophysiology 27 ( 12 ): 1659 – 1669 .
   PubMed Web of Science ®Google Scholar
• Patterson , S. , Jones , B. ( 2006 ). Bioequivalence and Statistics in Clinical Pharmacology London , UK : Chapman and Hall .
   Google Scholar
• R Development Core Team . ( 2011 ). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. http://www.r-project.org
   Google Scholar
• Schall , R. , Ring , A. ( 2010 ). Mixed models for data from thorough QT studies: Part 1. Assessment of marginal QT prolongation . Pharmaceutical Statistics 10 ( 3 ): 265 – 276 .
   PubMed Web of Science ®Google Scholar
• Schall , R. ( 2010 ). Mixed models for data from thorough QT studies: Part 2. One-step assessment of conditional QT prolongation . Pharmaceutical Statistics 10 ( 4 ): 293 – 301 .
   PubMed Web of Science ®Google Scholar
• Sethuraman , V. , Sun , Q. ( 2009 ). Impact of baseline ECG collection on the planning, analysis and interpretation of ‘through’ QT trials . Pharmaceutical Statistics 8 : 113 – 124 .
   PubMed Web of Science ®Google Scholar
• Tyl , B. , Azzam , S. , Reinbolt , E. , Blanco , N. , Olbertz , J. , Wheeler , W. ( 2010 ). Choice of baseline in a multiple-dose through QT study (TQTS)—Effect on analysis of moxifloxacin-induced QTc prolongation . Journal of Clinical Trials 2 : 1 – 7 .
   Google Scholar
• Williams , E. J. ( 1949 ). Experimental designs balanced for the estimation of residual effects of treatments . Australian Journal of Scientific Research 2 : 149 – 168 .
   Google Scholar
• Zhang , J. , Machado , S. G. ( 2008 ). Statistical issues including design and sample size calculation in thorough QT/QTc studies . Journal of Biopharmaceutical Statistics 18 ( 3 ): 451 – 467 .
   PubMed Web of Science ®Google Scholar
• Zhang , X. P. , Silkey , M. , Schumacher , M. , Wang , L. , Raval , H. , Caulfield , J. P. ( 2009 ). Period correction of the QTc of moxifloxacin with multiple predose baseline ECGs is the least variable of 4 methods tested . Journal of Clinical Pharmacology 49 : 534 – 539 .
   PubMed Web of Science ®Google Scholar